Inicio
Markets
Charts & Ideas
Algo
Noticias
Store
Corredores
Descargar
Calendario económico
Señales Comerciales
WebTerminal
Pulse
/
para buscar: @user, $symbol, ...
Buscar
Entrada
Crear una cuenta
Español
English
Русский
中文
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
ZVRA
#2506
Zevra Therapeutics, Inc. Common Stock
8.930
0
+0.68%
Sector:
Básica:
Profit Currency:
Rango diario
Rango anual
Cambio diario
+0.68%
Monthly Change
0.00%
6 month change
-16.07%
Cambio anual
-16.07%
Cierres anteriores
8.870
0
Open
8.930
0
Bid
Ask
Low
8.930
0
High
8.930
0
Volumen
101
Markets
Acciones
Atención Sanitaria
ZVRA
Open full chart
Financials
Overview
Statement
Statistics
Dividends
Quarterly
Annual
Value
2020
2021
2022
2023
2024
TTM
Key stats
Total common shares outstanding
28.38 M
34.42 M
34.54 M
43.43 M
54.12 M
—
Valuation ratios
Enterprise value
—
—
—
253.55 M
417.54 M
1.72 B
Price to earnings ratio
—
—
—
5.26
3.66
15.31
Price to sales ratio
—
—
—
8.82
16.34
39.01
Price to cash flow ratio
—
—
—
7.22
5.54
40.12
Price to book ratio
—
—
—
3.91
9.72
14.94
Enterprise value to EBITDA ratio
—
—
—
-5.12
-4.81
15.41
Profitability ratios
Return on assets %
1.14
0.06
0.36
0.27
0.59
0.51
Return on equity %
0.19
0.07
0.48
0.74
2.66
1.62
Return on invested capital %
551.89
270.19
707.94
249.94
249.48
426.9
Gross margin %
100
100
96.72
89.28
42.18
308.33
Operating margin %
42.21
26.98
406.44
180.63
368.47
443.72
EBITDA margin %
—
—
-42.2
-180.26
-367.86
131.87
Net margin %
96.03
29.86
397.24
167.69
446.85
600.79
Liquidity ratios
Quick ratio
—
—
—
1.05
2.47
21.45
Current ratio
1.11
27.2
7.93
1.18
2.53
22.02
Inventory turnover
—
—
—
—
2.31
8.41
Asset turnover
1.22
0.4
0.08
0.19
0.13
0.4
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
Long term debt to total assets ratio
6.07
0
0.11
0.03
0.33
1.15
Long term debt to total equity ratio
1.02
0
0.15
0.08
1.5
3.94
Per share metrics
Operating cash flow per share
—
0.35
0.54
0.95
1.51
0.48
EBIT per share
—
—
-0.16
-1.42
-2.02
0.85
EBITDA per share
—
—
-0.13
-1.4
-1.88
0.95
Total debt per share
—
—
—
—
—
—
Cash per share
—
3.77
2.4
1.91
1.5
9.82
Net current asset value per share
—
3.87
2.7
2.45
1.86
11.41
Tangible book value per share
—
4.27
2.49
-0.34
-0.74
2.74
Working capital per share
—
3.72
2.36
0.37
1.12
9.2
Book value per share
—
4.27
2.49
1.75
0.86
6.08
Noticias
Aclaris Therapeutics (ACRS) Reports Q4 Loss, Lags Revenue Estimates
Ironwood Pharmaceuticals (IRWD) Reports Q4 Loss, Lags Revenue Estimates
Neil F. McFarlane, presidente de Zevra Therapeutics, vende acciones por $125k
Neil F. McFarlane, presidente de Zevra Therapeutics, vende acciones por 125.000 dólares
Neil F. McFarlane, Zevra Therapeutics president, sells $125k in shares
Joshua Schafer, CCO de Zevra, vende acciones de ZVRA por 29.800 dólares
CMO de Zevra Therapeutics vende acciones por $40,000
El CMO de Zevra Therapeutics, Quartel, vende acciones por 40.000 dólares
Joshua Schafer, CCO de Zevra, vende acciones de ZVRA por $29,800
Zevra Therapeutics CMO Quartel sells $40k in shares
Schafer Joshua, CCO of Zevra, sells $29,800 in ZVRA stock
El director ejecutivo de Zevra Therapeutics, McFarlane, vende acciones por 853.000 dólares